Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo

International Journal of Dermatology

Volumn 46, Issue 8, 2007, Pages 875-879

  Sethi, Shweta ^a,b,c   Mahajan, Bharat Bhushan ^a,b   Gupta, Rajesh Rani ^a,b   Ohri, Ashish ^a,b  

^a GGS Medical College   (India)

^b DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^c Opp Bank of Punjab   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; FLUOROURACIL; FRAMYCETIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACENTA EXTRACT; PLACENTREX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BANDAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; GEL; HUMAN; MALE; SKIN SURGERY; VITILIGO;

ADMINISTRATION, TOPICAL; ADULT; CICATRIX, HYPERTROPHIC; COMBINED MODALITY THERAPY; DERMABRASION; DERMATOLOGIC AGENTS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; OCCLUSIVE DRESSINGS; PLACENTAL EXTRACTS; SKIN; TREATMENT OUTCOME; VITILIGO; WOUND HEALING;

EID: 34547439268     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03226.x     Document Type: Article

References (16)

1. Lerner AB. On the etiology of vitiligo and grey hair. Am J Med 1971; 51: 141-147.
2. Kenny JA Jr. Vitiligo treated by psoralens. A long term follow up study of the permanency of repigmentation. Arch Dermatol 1971; 103: 475-480.
3. Kandil E. Vitiligo: Response to 0.2% betamethasone 17 valerate in flexible colloidion. Dermatologica 1970; 141: 277-281.
4. Mahajan BB, Gupta RR, Garg G. Evaluation of cosmetic tattooing in localized stable vitiligo. J Dermatol 2002; 29: 726-730.
5. Gokhale BB, Tawada YV, Bharatia PR. Use of organ cultured foetal skin in allografts in treatment of resistant vitiligo. Indian J Dermatol Venereol Leprol 1991; 57: 272-275.
6. Falabella R, Escobar C, Borrero I. Treatment of refractory and stable vitiligo by in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol 1992; 26: 230-236.
7. Falabella R. Grafting and transplantation of melanocytes for repigmenting vitiligo and other types of stable leukoderma. Int J Dermatol 1989; 28: 263-269.
8. Koga M. Epidermal grafting using the tops of suction blisters in the treatment of vitiligo. Arch Dermatol 1988; 124: 1656-1658.
9. Behl PN. Treatment of vitiligo with homologous thin Thiersch skin grafts. Curr Med Pract 1964; 8: 218-221.
10. Tsuji T, Hamada T. Topically administered fluorouracil in vitiligo. Arch Dermatol 1983; 119: 722-727.
11. Sharma SK, Jain RK, Sharma AK. Topical human placental extract for the treatment of vitiligo. Indian J Dermatol Venereol Leprol 1988; 54: 199-201.
12. Biswas TK, Auddy B, Bhattacharya NP, et al. Wound healing activity of human placental extract in rats. Acta Pharmacol Sin 2001; 22: 1113-1116.
13. Ortonne JP, MacDonald DM, Micaud A. PUVA induced repigmentation of vitiligo: A histochemical (split DOPA) and ultrastructural study. Br J Dermatol 1979; 101: 1-12.
14. Hrushesky WJ. Serpentine supravenous fluorouracil hyperpigmentation. J Am Med Assoc 1976; 236: 138.
15. Kaplan LA, Walter JF, Macknet KD. Hypertrophic scarring as a complication of fluorouracil therapy. Arch Dermatol 1979; 115: 1452.
16. Savant SS. Therapeutic spot and regional dermabrasion in stable vitiligo. Indian J Dermatol Venereol Leprol 1996; 62: 139-145.